Djordjevic Ilija, Sabashnikov Anton, Deppe A C, Kuhn E, Eghbalzadeh K, Merkle J, Maier J, Weber C, Azizov F, Sindhu D, Wahlers T
Department of Cardiothoracic Surgery, Heart Centre, University Hospital Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
ECMO Centre, University Hospital Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
J Artif Organs. 2019 Jun;22(2):110-117. doi: 10.1007/s10047-019-01092-9. Epub 2019 Jan 23.
Out-of-hospital extracorporeal membrane oxygenation (ECMO) implantation and ECMO transport have become a growing field useful for emergent treatment of heart or lung failure with increasing number of centers launching such service. This study was designed to present risk factors predicting 30-day mortality for patients receiving ECMO support in a newly launched ECMO retrieval service. From 01/2015 till 01/2017 28 consecutive patients received ECMO support in peripheral hospitals using a miniaturized portable Cardiohelp System (Maquet, Rastatt Germany) for heart, lung or heart/lung failure as a bridge-to-decision as a part of our newly launched ECMO retrieval service. Outcomes and predictors for 30-day mortality were presented. The mean age was 56 ± 15 (maximum 78) years. The mean ECMO support duration was 97 ± 100 h, whereas 11 patients (40%) were weaned off support and discharged from hospital. Presence of hemolysis (p = 0.041), renal failure (p = 0.016), lower platelet count before ECMO implantation (p = 0.001), and higher lactate 24 h after initiation of support (p = 0.006) were factors associated with 30-day mortality. Initial success of an ECMO retrieval service depends on logistic organization and clinical management. Taking into consideration highly deleterious effects of hemodynamic malperfusion of end organs, rapid initiation of ECMO support is a vital factor for survival. This is highlighted by predictive factors of early mortality that are associated with peripheral organ failure or complications.
院外体外膜肺氧合(ECMO)植入和ECMO转运已成为一个不断发展的领域,随着越来越多的中心开展此类服务,其对心脏或肺衰竭的紧急治疗很有用。本研究旨在呈现新开展的ECMO转运服务中接受ECMO支持患者30天死亡率的预测风险因素。从2015年1月至2017年1月,28例连续患者在周边医院接受ECMO支持,使用小型便携式Cardiohelp系统(德国拉施塔特迈柯唯公司)治疗心脏、肺或心肺衰竭,作为决策桥梁,这是我们新开展的ECMO转运服务的一部分。呈现了30天死亡率的结果和预测因素。平均年龄为56±15(最大78)岁。平均ECMO支持时长为97±100小时,其中11例患者(40%)撤机并出院。溶血(p = 0.041)、肾衰竭(p = 0.016)、ECMO植入前血小板计数较低(p = 0.001)以及支持开始后24小时乳酸水平较高(p = 0.006)是与30天死亡率相关的因素。ECMO转运服务的初步成功取决于后勤组织和临床管理。考虑到终末器官血流动力学灌注不良的高度有害影响,快速启动ECMO支持是生存的关键因素。这一点在与外周器官衰竭或并发症相关的早期死亡率预测因素中得到了突出体现。